Celldex Therapeutics
CLDX
CLDX
134 hedge funds and large institutions have $295M invested in Celldex Therapeutics in 2017 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 42 increasing their positions, 44 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
134
Holders Change
-6
Holders Change %
-4.29%
% of All Funds
3.34%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
19
Increased
42
Reduced
44
Closed
19
Calls
$1.4M
Puts
$1.27M
Net Calls
+$134K
Net Calls Change
+$105K
Top Buyers
| 1 |
1
BlackRock
New York
|
$29.3M |
| 2 |
MG
2
Meditor Group
Hamilton,
Bermuda
|
$15M |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$32.7M |
| 4 |
4
Renaissance Technologies
New York
|
$6.17M |
| 5 |
5
State of Wisconsin Investment Board
Madison,
Wisconsin
|
$2.71M |
